Irvine, Calif. - Allergan Inc., contrary to popular belief, isn't fighting the U.S. Food and Drug Administration's allegations that statements in Botox Cosmetic advertisements are misleading, thus violating of the Food, Drug, and Cosmetic Act.
Addressing Disparities in Skin-Aging Prevention Among Women of Color
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Botulinum Toxin, Dermal Fillers Generally Effective and Well-Tolerated in Skin of Color Populations
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Muneeb Shah, DO: Behind the Scenes of Launching a Skin Care Brand
Allergan Aesthetics Launches New Book to Bring More Awareness to Ethics in Aesthetics